-
THE SAFETY AND EFFECTIVENESS OF STERILE HYPOCHLOROUS ACID USED AS SURGICAL IRRIGATION SOLUTION TO REDUCE POSTOPERATIVE COMPLICATIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Mar 18, 2026, 21:38 PM -
CHOOSING PUBLIC LLMS AND AI AGENTS FOR PATIENT OUTCOMES RESEARCH: PRACTICAL PROS/CONS AND GOVERNANCE IMPLICATIONS
Mar 18, 2026, 21:38 PM -
CHARACTERIZING THE PATIENT JOURNEY, HEALTH CARE RESOURCE UTILIZATION, AND ECONOMIC IMPACT OF PATIENTS WITH PTLD: A U.S. CLAIMS ANALYSIS
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS ANALYSIS OF BIREOCICLIB VERSUS ABEMACICLIB IN HR+/HER2- ADVANCED OR METASTATIC BREAST CANCER: COMPARING MATCHING-ADJUSTED INDIRECT COMPARISON AND SIMULATED TREATMENT COMPARISON APPROACHES
Mar 18, 2026, 21:38 PM -
A LIVING NETWORK META-ANALYSIS FRAMEWORK FOR COMPARATIVE EFFECTIVENESS RESEARCH IN CHRONIC VENOUS INSUFFICIENCY TREATMENT
Mar 18, 2026, 21:38 PM -
ETHICAL AI DEPLOYMENT IN HEOR
Mar 18, 2026, 21:38 PM -
EVALUATING THE COST EFFECTIVENESS OF HPV VACCINATION IN EGYPT
Mar 18, 2026, 21:38 PM -
BUDGET IMPACT ANALYSIS OF OFATUMUMAB FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS IN MOROCCO: A PROBABILISTIC MULTI-SCENARIO ASSESSMENT FROM THE PUBLIC PAYER PERSPECTIVE
Mar 18, 2026, 21:38 PM -
TRENDS IN BACK PAIN HEALTHCARE UTILIZATION AND EXPENDITURES AMONG U.S. ADULTS: 2007 VS 2023
Mar 18, 2026, 21:38 PM -
THE COST-EFFECTIVENESS ANALYSIS OF INATICABTAGENE AUTOLEUCEL FOR RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS IN CHINA
Mar 18, 2026, 21:38 PM -
REPORTING OF STUDY DETAILS IN ABSTRACTS: INFORMATIVE FOR ARTIFICIAL INTELLIGENCE (AI) OR UNDERWHELMING?
Mar 18, 2026, 21:38 PM -
TRENDS IN SPECIALTY DRUG COVERAGE POLICY COMPLEXITY AMONG US COMMERCIAL HEALTH PLANS
Mar 18, 2026, 21:38 PM -
INCREASED HEALTHCARE COSTS AND RESOURCE UTILIZATION FOLLOWING PROGRESSION IN PATIENTS WITH HR+/HER2- METASTATIC BREAST CANCER RECEIVING CHEMOTHERAPY
Mar 18, 2026, 21:38 PM -
COMPARATIVE ANALYSIS OF CAR T-CELL THERAPY ALONE VERSUS CAR T-CELL THERAPY WITH STEM CELL TRANSPLANT IN BLOOD CANCERS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF CLINICAL OUTCOMES
Mar 18, 2026, 21:38 PM -
IMPACT OF TELEMEDICINE ENCOUNTERS ON SURVIVAL OUTCOMES: A TIME-VARYING COX ANALYSIS USING EHR-DERIVED DATA
Mar 18, 2026, 21:38 PM -
PREDICTING CANCER’S NEXT MOVE AFTER LOCAL/REGIONAL RECURRENCE (LR) FOR HEALTH ECONOMIC EVALUATIONS: A PAN-TUMOR CASE STUDY
Mar 18, 2026, 21:38 PM -
BREAKING DOWN THE CITATION CHAIN IN HEALTH ECONOMIC MODELING: HOW FAR IS CURRENT PRACTICE FROM GUIDELINES (AND WHY GENAI MIGHT HELP)?
Mar 18, 2026, 21:38 PM -
HEALTH TECHNOLOGY ASSESSMENT OF LEVONORGESTREL-RELEASING INTRAUTERINE SYSTEMS IN INDIA: EVIDENCE FROM NETWORK META-ANALYSIS AND COST-EFFECTIVENESS MODELLING
Mar 18, 2026, 21:38 PM -
BRIDGING EVIDENCE AND ACCESS: SURVEY-BASED INSIGHTS INTO HOW BIOPHARMACEUTICAL MANUFACTURERS DEVELOP AND SHARE HCEI RESOURCES
Mar 18, 2026, 21:38 PM -
ASSOCIATIONS OF SOCIODEMOGRAPHIC AND CLINICAL FACTORS WITH GLP-1 RECEPTOR AGONIST UTILIZATION AMONG U.S. ADULTS WITH DIABETES, A CROSS-SECTIONAL ANALYSIS OF 2024 NHIS DATA
Mar 18, 2026, 21:38 PM
